Carterra

#Carterra #Drug discovery #Lab in the loop #Small molecules

Carterra advances lab-in-the-loop drug discovery  

Carterra, a provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule drug discovery, has collaborated with AstraZeneca to develop hardware and software aimed at advancing lab-in-the loop drug discovery.   Lab-in-the-loop – the model in which AI systems propose drug candidates, wet-lab experiments generate… Read More

#News

Monoclonal antibody
#AI models #Antibody discovery #Carterra #Lab in the loop

Carterra at centre of US$7bn antibody discovery market

In a report published on July 16 2026, titled Lab-in-the-Loop: AI Rewires Antibody Discovery, Unlocking a US$7 billion LST Opportunity, “Lab-in-the-Loop” (LitL) is described as an emerging approach in which AI models propose candidate antibody sequences, wet lab experiments test them, and the resulting data is fed back into the… Read More

#News